Maja Denkovski
YOU?
Author Swipe
View article: First‐Line Therapy for <scp><i>Helicobacter pylori</i></scp> in Slovenia: Data From 2013 to 2023 of the European Registry on <scp><i>H. pylori</i></scp> Management
First‐Line Therapy for <span><i>Helicobacter pylori</i></span> in Slovenia: Data From 2013 to 2023 of the European Registry on <span><i>H. pylori</i></span> Management Open
Background Treatment is indicated for all Helicobacter pylori infections. However, the best approach for H. pylori management remains unclear. Methods H. pylori eradication data from Hp‐EuReg on treatment‐naive patients in Slovenia from 20…
View article: Indications of <i>Helicobacter pylori</i> Eradication Treatment and Its Influence on Prescriptions and Effectiveness (Hp‐<scp>EuReg</scp>)
Indications of <i>Helicobacter pylori</i> Eradication Treatment and Its Influence on Prescriptions and Effectiveness (Hp‐<span>EuReg</span>) Open
Background The influence of indications for Helicobacter pylori investigation on prescriptions and effectiveness is unknown. The aim of the study was to assess the impact of indications for H. pylori investigation on prescriptions, effecti…
View article: Biological treatment approach to inflammatory bowel disease is similar in academic and nonacademic centres – prime time for decentralisation of inflammatory bowel disease care?
Biological treatment approach to inflammatory bowel disease is similar in academic and nonacademic centres – prime time for decentralisation of inflammatory bowel disease care? Open
Background With the increasing number of inflammatory bowel disease (IBD) patients, it is difficult to manage them within specialised IBD teams in academic medical centres: many are therefore treated in nonacademic IBD centres. It is uncle…
View article: Role of proton pump inhibitors dosage and duration in <i>Helicobacter pylori</i> eradication treatment: Results from the European Registry on <i>H. pylori</i> management
Role of proton pump inhibitors dosage and duration in <i>Helicobacter pylori</i> eradication treatment: Results from the European Registry on <i>H. pylori</i> management Open
Background Management of Helicobacter pylori ( H. pylori ) infection requires co‐treatment with proton pump inhibitors (PPIs) and the use of antibiotics to achieve successful eradication. Aim To evaluate the role of dosage of PPIs and the …
View article: Author Correction: Comparison of the management of Helicobacter pylori infection between the older and younger European populations
Author Correction: Comparison of the management of Helicobacter pylori infection between the older and younger European populations Open
View article: Comparison of the management of Helicobacter pylori infection between the older and younger European populations
Comparison of the management of Helicobacter pylori infection between the older and younger European populations Open
View article: Helicobacter pylori Diagnostic Tests Used in Europe: Results of over 34,000 Patients from the European Registry on Helicobacter pylori Management
Helicobacter pylori Diagnostic Tests Used in Europe: Results of over 34,000 Patients from the European Registry on Helicobacter pylori Management Open
Background and aims: Several methods are available to diagnose Helicobacter pylori infection. Our objective was to evaluate the tests used for both the initial diagnosis and the confirmation of eradication after treatment in Europe. Method…
View article: Effectiveness and Safety of High-Dose Dual Therapy: Results of the European Registry on the Management of Helicobacterpylori Infection (Hp-EuReg)
Effectiveness and Safety of High-Dose Dual Therapy: Results of the European Registry on the Management of Helicobacterpylori Infection (Hp-EuReg) Open
Background: Randomized clinical trials and meta-analyses, primarily from Asian countries, have reported good effectiveness with high-dose dual therapy (HDDT) including a proton pump inhibitor (PPI) and amoxicillin when prescribed as H. pyl…